Sanofi
SAN
อันดับในหุ้น
#224
Sanofi is a global healthcare enterprise dedicated to the research,... Sanofi is a global healthcare enterprise dedicated to the research, development, manufacturing, and commercialization of therapeutic solutions across the United States, Europe, and other international markets. Its business is structured into three primary divisions: Pharmaceuticals, Vaccines, and Consumer Healthcare. The Pharmaceuticals segment delivers specialized treatments, encompassing human monoclonal antibodies and therapies for a range of conditions such as multiple sclerosis, neurological disorders, various inflammatory and immunological diseases, rare disorders, oncology, and rare blood conditions. This division also provides medications for diabetes, cardiovascular health, and a portfolio of established prescription drugs. Through its Vaccines division, Sanofi supplies crucial immunizations, including pediatric vaccines for diseases like poliomyelitis, pertussis, and Hib, alongside adult vaccines addressing influenza, booster needs, meningitis, and those required for travel or endemic regions. The Consumer Healthcare portfolio features over-the-counter remedies for common ailments such as allergies, coughs and colds, and pain relief. It also includes products for liver care, general physical and mental wellness, probiotics, digestive health, and nutritional support. Additionally, this segment offers personal care items like daily body lotions, anti-itch products, moisturizing and soothing lotions, body and foot creams, and powders for eczema. Sanofi maintains an active pipeline with numerous pharmaceutical products and vaccines currently undergoing various stages of development. The company has forged strategic alliances, including a collaboration with GlaxoSmithKline for the development of a recombinant Covid-19 vaccine, a research partnership with Stanford University School of Medicine aimed at advancing immunology and inflammation knowledge, and a collaboration and license option agreement with Prellis Biologics, Inc. Founded in 1973 and headquartered in Paris, France, the company operated as Sanofi-Aventis before rebranding to Sanofi in May 2011.
ราคาหุ้น
$83.84
มูลค่าตลาด
$100.45B
การเปลี่ยนแปลง (1 วัน)
1.48%
การเปลี่ยนแปลง (1 ปี)
-16.74%
ประเทศ
FR
ซื้อขาย Sanofi (SAN)
หมวดหมู่
Healthcare
รายได้ของ Sanofi (SAN)
รายได้ใน 2026 TTM: 0
ตามรายงานทางการเงินล่าสุดของ Sanofi กำไรปัจจุบันของบริษัทคือ 0 ในปี 2026 บริษัทมีกำไร 0 ซึ่ง เท่ากับ กำไรในปี 2026 ที่อยู่ที่ 0 กำไรที่แสดงในหน้านี้คือกำไรก่อนหักดอกเบี้ยและภาษี หรือที่เรียกว่า EBIT
ประวัติรายได้ของ Sanofi ตั้งแต่ 2001 ถึง 2026
รายได้ ณ สิ้นปีแต่ละปี
| ปี | รายได้ | เปลี่ยน |
|---|---|---|
| 2025 | $7.06B | 0.44% |
| 2024 | $7.03B | 4.03% |
| 2023 | $6.76B | -36.93% |
| 2022 | $10.72B | 20.27% |
| 2021 | $8.91B | -48.24% |
| 2020 | $17.22B | 410.31% |
| 2019 | $3.37B | -40.13% |
| 2018 | $5.64B | -16.37% |
| 2017 | $6.74B | 10.21% |
| 2016 | $6.11B | 7.85% |
| 2015 | $5.67B | -16.42% |
| 2014 | $6.78B | 9.05% |
| 2013 | $6.22B | -23.52% |
| 2012 | $8.13B | 18.11% |
| 2011 | $6.89B | -8.02% |
| 2010 | $7.49B | -13.94% |
| 2009 | $8.70B | -34.25% |
| 2008 | $13.23B | 56.54% |
| 2007 | $8.45B | 35.27% |
| 2006 | $6.25B | 100.19% |
| 2005 | $3.12B | -224.94% |
| 2004 | $-2.50B | -163.40% |
| 2003 | $3.94B | 49.74% |
| 2002 | $2.63B | 38.31% |
| 2001 | $1.90B | 0.00% |
รายได้ของบริษัทหรือคู่แข่งที่คล้ายกัน
| บริษัท | รายได้ | ความแตกต่างของรายได้ | ประเทศ |
|---|---|---|---|
| $33.60B | - |
US
|
|
| $17.74B | - |
US
|
|
| $8.70B | - |
US
|
|
| $5.95B | - |
US
|
|
| $21.39B | - |
CH
|
